ATE380799T1 - Biguanid-derivate und deren verwendung als antidiabetika - Google Patents

Biguanid-derivate und deren verwendung als antidiabetika

Info

Publication number
ATE380799T1
ATE380799T1 AT03719160T AT03719160T ATE380799T1 AT E380799 T1 ATE380799 T1 AT E380799T1 AT 03719160 T AT03719160 T AT 03719160T AT 03719160 T AT03719160 T AT 03719160T AT E380799 T1 ATE380799 T1 AT E380799T1
Authority
AT
Austria
Prior art keywords
biguanide derivatives
antidiabetic drugs
optionally substituted
substituted lower
biguanide
Prior art date
Application number
AT03719160T
Other languages
English (en)
Inventor
Naoki Taka
Hiroharu Matsuoka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE380799T1 publication Critical patent/ATE380799T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03719160T 2002-04-26 2003-04-22 Biguanid-derivate und deren verwendung als antidiabetika ATE380799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002126878 2002-04-26

Publications (1)

Publication Number Publication Date
ATE380799T1 true ATE380799T1 (de) 2007-12-15

Family

ID=29267619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03719160T ATE380799T1 (de) 2002-04-26 2003-04-22 Biguanid-derivate und deren verwendung als antidiabetika

Country Status (7)

Country Link
US (1) US7396858B2 (de)
EP (1) EP1500656B1 (de)
JP (1) JP4393203B2 (de)
AT (1) ATE380799T1 (de)
AU (1) AU2003235359A1 (de)
DE (1) DE60318033T2 (de)
WO (1) WO2003091234A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006296251A (ja) * 2005-04-19 2006-11-02 Gunze Ltd α−グルコシダーゼ阻害剤
US11701336B2 (en) * 2015-10-30 2023-07-18 Yasumasa Kato Method of determining composition effective for treating diabetes
US10344002B2 (en) 2016-09-26 2019-07-09 Nusirt Sciences, Inc. Compositions and methods for treating metabolic disorders
CN110201167B (zh) * 2019-07-03 2021-08-27 西南大学 光照释放氧气的载酶硒化铋纳米粒子的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2961377A (en) * 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
JPS6024790B2 (ja) 1977-06-27 1985-06-14 大鵬薬品工業株式会社 ビグアナイド誘導体

Also Published As

Publication number Publication date
EP1500656B1 (de) 2007-12-12
AU2003235359A1 (en) 2003-11-10
DE60318033D1 (de) 2008-01-24
WO2003091234A1 (fr) 2003-11-06
EP1500656A4 (de) 2006-09-06
EP1500656A1 (de) 2005-01-26
US7396858B2 (en) 2008-07-08
DE60318033T2 (de) 2008-12-04
US20050124693A1 (en) 2005-06-09
JP4393203B2 (ja) 2010-01-06
JPWO2003091234A1 (ja) 2005-09-02

Similar Documents

Publication Publication Date Title
ATE264856T1 (de) Heterocyclisch substituierte benzolderivate und herbizide
DE602005004810D1 (de) Hautpflegeverfahren gegen alterserscheinungen mit quaternären ammoniumsalzen als wirkstoffe
MXPA04007018A (es) Quinazolina(di)onas para control de plagas de invertebrados.
ATE493395T1 (de) Anthranilamide, verfahren zu deren herstellung und diese enthaltende schädlingsbekämpfungsmittel
ECSP055615A (es) Nuevos compuestos de amida de ácido carboxílico con efecto antagónico de la hcm, medicamentos que contienen estos compuestos y procedimientos para su preparación
CO5590860A2 (es) Compuestos de sulfonilurea de heterociclico condensado, herbicida, que contiene el mismo para controlar maleza con el mismo
GB0206860D0 (en) Compounds
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
DK0698606T3 (da) Azolylaminderivat
DE602004012758D1 (de) Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung
DE69813605D1 (de) Benzofuranderivate
DK1395117T3 (da) Anvendelse af triazolopyrimidinderivater som mikrobicider i materialebeskyttelse
ATE311106T1 (de) Insektizide amide mit stickstoffhaltigen kondensierten bizyklischen ringsystemen
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
DE602004014727D1 (de) Aminoalkoholderivate, pharmazeutische zusammensetzungen, die diese enthalten, und verwendung davon
ATE449066T1 (de) Biguanidderivate
ATE380799T1 (de) Biguanid-derivate und deren verwendung als antidiabetika
ATE250021T1 (de) Hydroxycyclopentanone
TW200509795A (en) Insecticidal phthalamide derivatives
ATE252537T1 (de) Substituierte 2-hydroxybenzophenone, ihre herstellung, ihre verwendung als fungizide und ihre fungizide zusammensetzungen
BRPI0206922B8 (pt) composto de fragrância, composição de fragrância contendo o mesmo, e método para preparação de um composto de fragrância
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
DE60006053D1 (de) 2-Aryloxy-4-methyl-6-pyrazol-1-yl-pyridine wirksam als Herbizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties